Recursion Pharmaceuticals Inc. has announced the grant of inducement restricted stock unit (RSU) awards to 17 new employees, totaling 820,431 shares of its class A common stock under the company's 2024 Inducement Equity Incentive Plan. Each RSU award will vest 25% of the shares on the first quarterly vesting date after the one-year anniversary of the vesting commencement date, with the remaining shares vesting in 1/16th increments on each subsequent quarterly vesting date, contingent on continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9653401-en) on February 12, 2026, and is solely responsible for the information contained therein.